iQure Pharma Inc.

New Filing
CIK: 0001996977·Other·DELAWARE·Filed: Jun 3, 2026
Total Offering

$4,000,000

Amount Sold

$650,000

Investors

1

First Sale

May 27, 2026

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Pawel Zolnierczyk

Company

iQure Pharma Inc.

3 KITTANSETT COURT

SKILLMAN, NJ, 08558

3122911382

SEC Filing

0001996977-26-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
iQure Pharma Inc. Form D Filing — $4,000,000 | FilingFlow